-
Accelerated rTMS in mood disorders: a neurobiological point of view
Prof. Dr. Chris Baeken (MD, PhD)
-
Performance monitoring, post-error adjustments, and acetylcholine
Prof. Dr. med. habil. Markus Ullsperger
-
To be announced
John J. Foxe, PhD
-
The pull of environmental affordances on selective attention
Dr. Zakaria Djebbara
-
To be announced
Prof. John Rothwell
-
Repetitive transcranial magnetic stimulation improves postoperative functional recovery in glioma patients: insights from Beijing Tiantan Hospital
Dr. Fan Xing on behalf of Prof. Jiang Tao
-
Mechanisms Behind Neurotechnology-Assisted Rehabilitation: First Results from a Double-Blind Randomized Controlled Trial
Reinhold Scherer, PhD
-
To be announced
Prof. Dr. Elsa Kirchner
-
Non-Invasive Remote EEG Monitoring at Home in Epilepsy: Insights from the EEG@HOME Study
Dr. Andrea Biondi
-
To be announced.
Prof. Dr. Patrique Fiedler
Sebastian Olbrich studied medicine in Munich, Germany, and completed specialized training in psychiatry at the University of Leipzig. Since 2014, he has been part of the University Hospital Zurich, where he now serves as the Chief of the Center for Depression, Anxiety Disorders, and Psychotherapy. His research focuses on identifying predictive biomarkers for treatment outcomes in psychiatric disorders, with a particular emphasis on depression. Dr. Sebastian Olbrich and his team are pioneers in using advanced deep learning techniques to analyze EEG and ECG time series data, striving to achieve the highest possible accuracy in their predictive models. He is also the co-founder of DeepPSY, a company that develops EEG/ECG-based medical reports for personalized treatment recommendations.
While thorough examination of the affected organ is standard practice in many medical fields, psychiatric treatment decisions remain largely guided by expert opinion and patient history. Over the past decade, however, mounting evidence has shown that electroencephalogram (EEG) and electrocardiogram (ECG) time series data contain valuable information that can not only enhance diagnostic processes—moving beyond rigid diagnostic categories—but, more importantly, assist in matching patients with the most effective treatments.
This talk will explore the development of electrophysiological treatment markers, from conventional research findings such as frontal alpha asymmetry and EEG vigilance, to cutting-edge advancements in predictive EEG research using deep learning models. These innovations significantly improve the accuracy of treatment predictions. The presentation will highlight results from large international datasets on depression and other psychiatric disorders, offering insights into the future of personalized psychiatry. Further, an outlook will be given on the usage of automated analysis pipelines for clinical usage and as software as medical devices.